SpringWorks Therapeutics ... (SWTX)
36.51
0.69 (1.93%)
At close: Jan 28, 2025, 2:35 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| PE Ratio | -7.09 | -5.06 | -17.35 | -70.97 | -30.23 | -28.2 | -210.9 |
| PS Ratio | 422.99 | 225.49 | n/a | 89.72 | n/a | n/a | n/a |
| PB Ratio | 3.68 | -2.43 | 7.12 | 5.64 | 5.14 | -25.93 | -372.71 |
| P/FCF Ratio | -10.01 | -8.07 | -23.14 | -95.64 | -34.4 | -33.49 | -428.54 |
| P/OCF Ratio | -10.34 | -8.58 | -23.51 | -97.55 | -34.89 | -34.16 | -436.96 |
| OCF/S Ratio | -40.9 | -26.28 | n/a | -0.92 | n/a | n/a | n/a |
| Debt / Equity Ratio | 0.01 | -0.01 | 0.00 | 0.00 | n/a | n/a | n/a |
| Quick Ratio | 6.37 | 11.75 | 12.78 | 29.15 | 27.68 | 12.79 | 16.14 |
| Current Ratio | 6.41 | 11.75 | 12.78 | 29.15 | 27.68 | 12.79 | 16.14 |
| Asset Turnover | 0.01 | 0.01 | n/a | 0.06 | n/a | n/a | n/a |
| Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Return on Equity (ROE) | -0.52 | 0.48 | -0.41 | -0.08 | -0.17 | 0.92 | 1.77 |
| Return on Assets (ROA) | -0.45 | -0.44 | -0.38 | -0.08 | -0.16 | -0.37 | -0.44 |
| Return on Capital (ROIC) | -0.53 | -0.48 | -0.41 | -0.08 | -0.18 | -0.41 | -0.47 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 92.25% | 69.16% | n/a | 99.00% | n/a | n/a | n/a |
| Net Profit Margin | -5.97K% | -4.46K% | n/a | -126.41% | n/a | n/a | n/a |
| Pretax Profit Margin | -5.97K% | -4.51K% | n/a | -130.21% | n/a | n/a | n/a |
| Operating Profit Margin | -6.30K% | -4.57K% | n/a | -132.35% | n/a | n/a | n/a |
| FCF Margin | -4.23K% | -2.79K% | n/a | -93.81% | n/a | n/a | n/a |
| EBITDA Margin | -6.27K% | -4.57K% | n/a | -131.36% | n/a | n/a | n/a |